Spots Global Cancer Trial Database for warts
Every month we try and update this database with for warts cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts) | NCT05877313 | Verruca Plantar... | Sterile water f... Nitric Oxide | 12 Years - | Sanotize Research and Development corp. | |
A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome | NCT03087370 | WHIM Syndrome | No intervention | - | X4 Pharmaceuticals | |
Study With Candida Antigen for Treatment of Warts | NCT00569231 | Warts HPV | Candida Antigen | 18 Years - 50 Years | University of Arkansas | |
Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients | NCT00761371 | Warts | Imiquimod 5% cr... | 18 Years - 69 Years | Viatris Inc. | |
Serum Galectin-3 as a Marker of Human Papillomavirus Infection | NCT06005389 | Human Papilloma... | cryotherapy serum Galectin-... | 18 Years - 60 Years | Assiut University | |
Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts | NCT04399577 | Warts | Candida antigen | 9 Years - 45 Years | Zagazig University | |
CellFX System for the Treatment of Cutaneous Non-Genital Warts | NCT04554394 | Warts Warts Hand Verruca | CellFX Device | 21 Years - 80 Years | Pulse Biosciences, Inc. | |
A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts | NCT01468636 | Genital Warts HPV | Oral Zinc Placebo | 19 Years - | University of British Columbia | |
Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients | NCT00761371 | Warts | Imiquimod 5% cr... | 18 Years - 69 Years | Viatris Inc. | |
Cost-effectiveness of EndWarts® FREEZE - an Alternative Home Cryotherapy Device for Wart Treatment | NCT04781244 | Cryotherapy Eff... Warts | EndWarts® FREEZ... Liquid nitrogen | 18 Years - | Mahidol University | |
Cantharone for the Treatment of Perenial Warts | NCT03625960 | Wart, Genital | Cantharidin Trichloroacetic... | 18 Years - 75 Years | Wayne State University | |
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults | NCT00114920 | Warts | Resiquimod | 18 Years - | Graceway Pharmaceuticals, LLC | |
A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts | NCT01468636 | Genital Warts HPV | Oral Zinc Placebo | 19 Years - | University of British Columbia | |
Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts | NCT05291845 | Warts Human Papilloma... | Candida antigen... Bivalent HPV va... | 9 Years - | Zagazig University | |
Anogenital Wart Burden and Cost of Illnesses | NCT00749294 | Warts | 18 Years - | Mahidol University | ||
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo | NCT02902822 | Erysipelas Impetigo Herpes Zoster Molluscum Conta... Warts Tinea Melanoma Actinic Keratos... Basal Cell Carc... Squamous Cell C... | Screening Tele-dermatolog... | 18 Years - 99 Years | Centro Studi Gised | |
Efficacy of Laser Versus Cryotherapy in the Treatment of Warts | NCT01808443 | Warts | Cryotherapy laser | 18 Years - | The 306 Hospital of People's Liberation Army | |
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts | NCT04814446 | Palmar or Plant... | Vaccination | 15 Years - | Assistance Publique - Hôpitaux de Paris | |
Intralesional Vitamin D Injection for Treatment of Common Warts | NCT04278573 | Warts | Vitamin D3 Placebo | 18 Years - | Mayo Clinic | |
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts | NCT04738734 | Warts Warts Hand Verruca | CellFX System D... Cryosurgery Liq... | 22 Years - 80 Years | Pulse Biosciences, Inc. | |
Triple Antigen vs Monoantigen Immunotherapy for Warts | NCT05254561 | Triple Intrales... | Intralesional a... | 10 Years - 70 Years | Zagazig University | |
Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts | NCT03158168 | Warts | Candida Antigen Zinc Sulfate | 5 Years - 50 Years | Assiut University | |
Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts | NCT05291845 | Warts Human Papilloma... | Candida antigen... Bivalent HPV va... | 9 Years - | Zagazig University | |
Intralesional HPV Vaccine for Condylomata | NCT05087849 | Human Papilloma... Warts Warts, Genital Condyloma Condylomata Acu... | nonavalent huma... | 18 Years - | University of California, San Francisco | |
Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts | NCT05616078 | Warts | laser treatment cryotherapy | 18 Years - | The 306 Hospital of People's Liberation Army | |
Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070) | NCT01567813 | Human Papilloma... | 9 Years - 26 Years | Merck Sharp & Dohme LLC | ||
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo | NCT02902822 | Erysipelas Impetigo Herpes Zoster Molluscum Conta... Warts Tinea Melanoma Actinic Keratos... Basal Cell Carc... Squamous Cell C... | Screening Tele-dermatolog... | 18 Years - 99 Years | Centro Studi Gised | |
Topical 5-ALA Photodynamic Therapy for the Treatment of Verruca Vulgaris | NCT00155584 | Warts | 10 Years - 80 Years | National Taiwan University Hospital | ||
Cost-effectiveness of EndWarts® FREEZE - an Alternative Home Cryotherapy Device for Wart Treatment | NCT04781244 | Cryotherapy Eff... Warts | EndWarts® FREEZ... Liquid nitrogen | 18 Years - | Mahidol University | |
Anogenital Wart Burden and Cost of Illnesses | NCT00749294 | Warts | 18 Years - | Mahidol University | ||
Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population. | NCT02567149 | Warts | Cidofovir | 12 Years - 17 Years | University of Minnesota | |
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts | NCT04428359 | Verruca Viral | Measles-Mumps-R... Vit D | 12 Years - | B.P. Koirala Institute of Health Sciences | |
Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial | NCT00254280 | Warts | Intense Pulsed ... | 18 Years - | Bispebjerg Hospital | |
Study With a Topical Gel to Treat Common Warts in Adults | NCT00117871 | Warts | Resiquimod | 18 Years - | Graceway Pharmaceuticals, LLC | |
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects | NCT00116675 | Warts | Resiquimod | 3 Years - 11 Years | Graceway Pharmaceuticals, LLC | |
Clinical Study : Efficacy and Safety of Three Cryotherapy Devices for Wart Treatment | NCT03129373 | Warts | Cryogenic treat... | 4 Years - | Oystershell NV | |
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands | NCT00973856 | Papillomavirus ... Warts Condylomata Acu... Epidermodysplas... | PURELL VF481 Placebo Solutio... | 18 Years - 75 Years | Cleveland Clinic Akron General | |
Efficacy and Safety of Topical Methotrexate Gel 1% Coupled With Microneedling in Treatment of Warts | NCT05300009 | Warts | topical methotr... Liquid nitrogen | 18 Years - 60 Years | Assiut University | |
Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts | NCT05781841 | Warts | Detection of ex... Detection of ex... Detection of ex... | 18 Years - 50 Years | Sohag University | |
Intralesional HPV Vaccine for Condylomata | NCT05087849 | Human Papilloma... Warts Warts, Genital Condyloma Condylomata Acu... | nonavalent huma... | 18 Years - | University of California, San Francisco | |
Cantharidin and Occlusion in Verruca Epithelium | NCT03487549 | Common Wart Warts Hand Warts Papillomavirus ... DNA Virus Infec... Skin Diseases, ... Skin Diseases, ... Skin Diseases Virus Diseases Tumor Virus Inf... Verruca Vulgari... Verruca | VP-102 Canthari... VP-102 Canthari... | 2 Years - | Verrica Pharmaceuticals Inc. | |
Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts) | NCT05877313 | Verruca Plantar... | Sterile water f... Nitric Oxide | 12 Years - | Sanotize Research and Development corp. | |
Candin Safety & Efficacy Study for the Treatment of Warts | NCT01757392 | Warts Human Papilloma... | Candida albican... | 18 Years - 65 Years | Nielsen BioSciences, Inc. | |
The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s) | NCT00546611 | Warts | PEP005 | 18 Years - | Peplin | |
CellFX System for the Treatment of Cutaneous Non-Genital Warts | NCT04554394 | Warts Warts Hand Verruca | CellFX Device | 21 Years - 80 Years | Pulse Biosciences, Inc. | |
A Comparative Study of Occlusive Heat Patch in the Treatment of Warts | NCT01746056 | Verruca (Warts) | Occlusive Heat ... | 5 Years - | Yale University | |
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts | NCT05712811 | Warts | CRYOTHERAPY Tricholoracetic... | 18 Years - 60 Years | Combined Military Hospital Abbottabad | |
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts | NCT05799157 | Verruca Vulgari... Warts Common Wart | VDMN-21 Patch L... VDMN-21 Patch H... Vehicle Patch | 12 Years - 65 Years | Veradermics, Inc. | |
Study With a Topical Gel to Treat Common Warts in Adults | NCT00117871 | Warts | Resiquimod | 18 Years - | Graceway Pharmaceuticals, LLC | |
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts | NCT04738734 | Warts Warts Hand Verruca | CellFX System D... Cryosurgery Liq... | 22 Years - 80 Years | Pulse Biosciences, Inc. | |
Candin Safety & Efficacy Study for the Treatment of Warts | NCT01757392 | Warts Human Papilloma... | Candida albican... | 18 Years - 65 Years | Nielsen BioSciences, Inc. | |
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) | NCT02393417 | Warts | CANDIN Placebo | 18 Years - 65 Years | Nielsen BioSciences, Inc. | |
Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial | NCT00254280 | Warts | Intense Pulsed ... | 18 Years - | Bispebjerg Hospital | |
Microwave Treatment of Common and Plantar Warts | NCT05371834 | Warts | Microwave Treat... Cryotherapy | 18 Years - 64 Years | Blackwell Device Consulting | |
Cantharidin and Occlusion in Verruca Epithelium | NCT03487549 | Common Wart Warts Hand Warts Papillomavirus ... DNA Virus Infec... Skin Diseases, ... Skin Diseases, ... Skin Diseases Virus Diseases Tumor Virus Inf... Verruca Vulgari... Verruca | VP-102 Canthari... VP-102 Canthari... | 2 Years - | Verrica Pharmaceuticals Inc. | |
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults | NCT00114920 | Warts | Resiquimod | 18 Years - | Graceway Pharmaceuticals, LLC | |
Study With a Topical Gel to Treat Common Warts in Adults | NCT00117923 | Warts | Resiquimod | 18 Years - | Graceway Pharmaceuticals, LLC | |
Clinical Trial to Evaluate Efficacy and Safety of a Cryogenic Medical Device for Treatment of Common and Plantar Warts | NCT06309420 | Warts | Cryogenic treat... Cryogenic treat... | 4 Years - | Oystershell NV | |
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts. | NCT06214559 | Warts Plantar Wart Common Wart | Sérum VERRUPRO | 18 Years - | Swiss Footcare Laboratories - Poderm Professional | |
Serum Galectin-3 as a Marker of Human Papillomavirus Infection | NCT06005389 | Human Papilloma... | cryotherapy serum Galectin-... | 18 Years - 60 Years | Assiut University | |
Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population. | NCT02567149 | Warts | Cidofovir | 12 Years - 17 Years | University of Minnesota | |
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts | NCT05799157 | Verruca Vulgari... Warts Common Wart | VDMN-21 Patch L... VDMN-21 Patch H... Vehicle Patch | 12 Years - 65 Years | Veradermics, Inc. | |
Efficacy of Laser Versus Cryotherapy in the Treatment of Warts | NCT01808443 | Warts | Cryotherapy laser | 18 Years - | The 306 Hospital of People's Liberation Army |